{"id":26456,"date":"2024-08-21T09:00:00","date_gmt":"2024-08-21T16:00:00","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=26456"},"modified":"2024-08-20T14:51:10","modified_gmt":"2024-08-20T21:51:10","slug":"ivig-for-lambert-eaton-myasthenic-syndrome","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-lambert-eaton-myasthenic-syndrome\/","title":{"rendered":"IgIV para el s\u00edndrome miast\u00e9nico de Lambert-Eaton"},"content":{"rendered":"<p><a href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/understanding-lambert-eaton-syndrome-a-rare-disorder\/\">S\u00edndrome miast\u00e9nico de Lambert-Eaton<\/a> (LEMS) es un trastorno autoinmune poco com\u00fan que afecta <a href=\"https:\/\/rarediseases.org\/rare-diseases\/lambert-eaton-myasthenic-syndrome\/\">2,8 millones de personas<\/a> En todo el mundo. En Estados Unidos, alrededor de 400 personas son diagnosticadas con LEMS.\u00a0<\/p>\n\n\n\n<div  id=\"call-to-action-45483ac5492bb8f5589224645cc42411\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tConsulte a un especialista en IgIV\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tLa mejor infusi\u00f3n de IgIV en casa\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p>El LEMS es un trastorno autoinmune poco com\u00fan de la uni\u00f3n neuromuscular causado por un ataque inmunitario. El da\u00f1o inmunitario en la uni\u00f3n neuromuscular afecta la transmisi\u00f3n de se\u00f1ales entre los nervios y los m\u00fasculos voluntarios, y causa debilidad muscular, fatiga y otros s\u00edntomas.&nbsp;<\/p>\n\n\n\n<p>Varios casos <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15959667\/\">informes<\/a> y controlado aleatorio <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15959667\/\">ensayos<\/a> han demostrado los efectos beneficiosos de la terapia con IgIV en pacientes con EMLE. Pacientes con EMLE <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15959667\/\">Experimente una mejora muscular significativa<\/a> despu\u00e9s de recibir tratamiento con IgIV como tratamiento de primera l\u00ednea.&nbsp;<\/p>\n\n\n\n<p>Este art\u00edculo analiza el papel del sistema inmunol\u00f3gico como causa del LEMS y c\u00f3mo la terapia con IgIV puede ayudar.<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-lambert-eaton-myasthenic-syndrome\/#How_Does_the_Immune_System_Cause_LEMS\" >\u00bfC\u00f3mo el sistema inmunol\u00f3gico causa LEMS?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-lambert-eaton-myasthenic-syndrome\/#Immune_System_and_Lambert-Eaton_Myasthenic_Syndrome_LEMS\" >Sistema inmunitario y s\u00edndrome miast\u00e9nico de Lambert-Eaton (LEMS)<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-lambert-eaton-myasthenic-syndrome\/#How_IVIG_Therapy_Can_Help_People_With_Lambert-Eaton_Myasthenic_Syndrome\" >C\u00f3mo la terapia con IgIV puede ayudar a las personas con s\u00edndrome miast\u00e9nico de Lambert-Eaton<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-lambert-eaton-myasthenic-syndrome\/#It_Neutralizes_the_Effects_of_Autoantibodies\" >Neutraliza los efectos de los autoanticuerpos<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-lambert-eaton-myasthenic-syndrome\/#It_Inhibits_the_Autoantibodies-Producing_Cells\" >Inhibe las c\u00e9lulas productoras de autoanticuerpos<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-lambert-eaton-myasthenic-syndrome\/#It_Reduces_Secondary_Inflammation\" >Reduce la inflamaci\u00f3n secundaria<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-lambert-eaton-myasthenic-syndrome\/#How_Is_IVIG_Therapy_Given_to_Patients_With_IVIG_for_Lambert-Eaton_Myasthenic_Syndrome\" >\u00bfC\u00f3mo se administra la terapia con IgIV a pacientes con IgIV para el s\u00edndrome miast\u00e9nico de Lambert-Eaton?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-lambert-eaton-myasthenic-syndrome\/#Is_IVIG_Used_as_a_Short-Term_Treatment_for_LEMS\" >\u00bfSe utiliza la IgIV como tratamiento a corto plazo para el LEMS?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-lambert-eaton-myasthenic-syndrome\/#Summary\" >Resumen<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Does_the_Immune_System_Cause_LEMS\"><\/span><strong>\u00bfC\u00f3mo el sistema inmunol\u00f3gico causa LEMS?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Generalmente, cuando una persona sana desea realizar una actividad, su cerebro env\u00eda se\u00f1ales a los m\u00fasculos a trav\u00e9s de los nervios. La comunicaci\u00f3n entre los nervios y los m\u00fasculos se produce mediante la acetilcolina (una sustancia qu\u00edmica que indica a los m\u00fasculos que se contraigan), que se libera al activarse los canales de calcio dependientes de voltaje (CCVV) en los extremos de las terminaciones nerviosas.<\/p>\n\n\n\n<p>Entonces, cuando se activan los canales de calcio dependientes de voltaje (VGCC), la acetilcolina se libera de las terminaciones nerviosas y se une a los receptores de la fibra muscular para provocar la contracci\u00f3n muscular.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Immune_System_and_Lambert-Eaton_Myasthenic_Syndrome_LEMS\"><\/span><strong>Sistema inmunitario y s\u00edndrome miast\u00e9nico de Lambert-Eaton (LEMS)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Las personas con s\u00edndrome miast\u00e9nico de Lambert-Eaton (SMLE) tienen autoanticuerpos (anticuerpos producidos por el sistema inmunitario contra c\u00e9lulas sanas) que bloquean estos canales de calcio en las terminaciones nerviosas. Como resultado, la menor cantidad de acetilcolina liberada por los nervios es insuficiente para provocar una contracci\u00f3n muscular normal.\u00a0<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_IVIG_Therapy_Can_Help_People_With_Lambert-Eaton_Myasthenic_Syndrome\"><\/span><strong>C\u00f3mo la terapia con IgIV puede ayudar a las personas con s\u00edndrome miast\u00e9nico de Lambert-Eaton<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>La terapia con IgIV es <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9792103\/\">Considerado un tratamiento de primera l\u00ednea para LEMS en personas con patrones refractarios de debilidad.<\/a> o cuando la terapia tradicional no funciona bien. Por ejemplo, una <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0960896614006348\">informe de caso<\/a> El estudio de una mujer de 34 a\u00f1os con debilidad progresiva de las extremidades que recibi\u00f3 tratamiento con IgIV mostr\u00f3 una mejor\u00eda en la fuerza muscular.&nbsp;<\/p>\n\n\n\n<p>De manera similar, seg\u00fan otro <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/12501987\/\">informe de caso<\/a>Una mujer de 65 a\u00f1os con c\u00e1ncer de pulm\u00f3n de c\u00e9lulas peque\u00f1as que ten\u00eda debilidad profunda y progresiva en las extremidades inferiores experiment\u00f3 una mejor\u00eda en la fuerza muscular despu\u00e9s de 3 semanas de tratamiento con IgIV.&nbsp;<\/p>\n\n\n\n<p>Aunque el mecanismo exacto de la IgIV no est\u00e1 claro, los investigadores creen que la IgIV puede ayudar a aliviar los s\u00edntomas del LEMS a trav\u00e9s de varios mecanismos relacionados, que son los siguientes:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"It_Neutralizes_the_Effects_of_Autoantibodies\"><\/span><strong>Neutraliza los efectos de los autoanticuerpos<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>En pacientes con LEMS, los autoanticuerpos producidos por el sistema inmunitario bloquean principalmente los canales de calcio dependientes de voltaje para impedir la liberaci\u00f3n de acetilcolina. Como resultado, los m\u00fasculos no se contraen correctamente.&nbsp;<\/p>\n\n\n\n<p>La terapia con IgIV funciona para <a href=\"https:\/\/www.nmd-journal.com\/article\/S0960-8966(14)00634-8\/abstract\">neutralizar el efecto de estos autoanticuerpos<\/a> En pacientes con EMLE. La IgIV impide que los autoanticuerpos se unan a los canales de calcio dependientes de voltaje. Esto ayuda a mejorar la funci\u00f3n muscular en pacientes con EMLE.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"It_Inhibits_the_Autoantibodies-Producing_Cells\"><\/span><strong>Inhibe las c\u00e9lulas productoras de autoanticuerpos<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Las c\u00e9lulas B, que generalmente producen anticuerpos sanos normales cuando est\u00e1n hiperactivas, comienzan a producir autoanticuerpos.&nbsp;<\/p>\n\n\n\n<p>La terapia con IgIV suprime la actividad de las c\u00e9lulas B y previene la producci\u00f3n de autoanticuerpos. Esto reduce el nivel de autoanticuerpos en el suero y <a href=\"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.47.3.678\">mejora la fuerza muscular en LEMS<\/a>.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"It_Reduces_Secondary_Inflammation\"><\/span><strong>Reduce la inflamaci\u00f3n secundaria<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Las propiedades antiinflamatorias de la terapia con IgIV ayudan a reducir cualquier inflamaci\u00f3n secundaria que pueda surgir en pacientes con LEMS durante ataques autoinmunes.\u00a0<\/p>\n\n\n\n<div  id=\"call-to-action-257e850645ebb0895e063b0cc2e0985a\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia para el copago de IgIV\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tHabla con un especialista\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Programar una consulta<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Is_IVIG_Therapy_Given_to_Patients_With_IVIG_for_Lambert-Eaton_Myasthenic_Syndrome\"><\/span><strong>\u00bfC\u00f3mo se administra la terapia con IgIV a pacientes con IgIV para el s\u00edndrome miast\u00e9nico de Lambert-Eaton?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"280\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ivig-2.jpg\" alt=\"A woman in a chair receiving IVIG for LEMS\" class=\"wp-image-26461\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ivig-2.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ivig-2-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ivig-2-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ivig-2-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ivig-2-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ivig-2-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ivig-2-370x247.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p>Los pacientes con s\u00edndrome miast\u00e9nico de Lambert-Eaton (SMLE) reciben terapia con IgIV cuando presentan una forma refractaria de SMLE. Se administra mediante infusi\u00f3n intravenosa con una dosis recomendada de 2 g\/kg durante 2 a 5 d\u00edas. El m\u00e9dico determinar\u00e1 la duraci\u00f3n de las infusiones seg\u00fan la respuesta del paciente al tratamiento.\u00a0<\/p>\n\n\n\n<p>La IgIV puede tardar entre 2 y 4 semanas en mejorar la debilidad.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Is_IVIG_Used_as_a_Short-Term_Treatment_for_LEMS\"><\/span><strong>\u00bfSe utiliza la IgIV como tratamiento a corto plazo para el LEMS?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Los estudios muestran que la terapia con IgIV se puede utilizar como tratamiento a corto y largo plazo en pacientes con LEMS, especialmente cuando los medicamentos inmunosupresores no son efectivos.&nbsp;<\/p>\n\n\n\n<p>Adem\u00e1s, los pacientes pueden experimentar diversos efectos secundarios asociados con la IgIV, como n\u00e1useas, dolor de cabeza o, en raras ocasiones, coagulaci\u00f3n durante el tratamiento. Por lo tanto, se recomienda consultar a un profesional de la salud si los s\u00edntomas persisten o empeoran.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Summary\"><\/span><strong>Resumen<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig\/\/ivig\/\">Terapia con IgIV<\/a> Se utiliza para tratar los s\u00edntomas de progresi\u00f3n r\u00e1pida del s\u00edndrome miast\u00e9nico de Lambert-Eaton (SMLE). En pacientes con SMLE, la IgIV neutraliza los autoanticuerpos que atacan las terminaciones nerviosas e inhibe la actividad de los linfocitos B autorreactivos. Mediante la modulaci\u00f3n del sistema inmunitario, la IgIV ayuda a reducir la gravedad de los s\u00edntomas y mejora la fuerza muscular en pacientes con SMLE.<\/p>","protected":false},"excerpt":{"rendered":"<p>Lambert-Eaton myasthenic syndrome (LEMS) is a rare autoimmune disorder that affects 2.8 million individuals worldwide. In the US, around 400 individuals are diagnosed with LEMS.\u00a0LEMS is a rare autoimmune neuromuscular junction disorder caused by an immune attack.<\/p>","protected":false},"author":7,"featured_media":26459,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[7],"tags":[8],"class_list":["post-26456","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ivig","tag-dr-christine-leduc"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IVIG for Lambert-Eaton Myasthenic Syndrome - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"description\" content=\"Read about IVIG for Lambert-Eaton Myasthenic Syndrome. Topics include how IVIG can help those with LEMS, how the therapy is given, and more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-lambert-eaton-myasthenic-syndrome\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IVIG for Lambert-Eaton Myasthenic Syndrome - AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"og:description\" content=\"Read about IVIG for Lambert-Eaton Myasthenic Syndrome. Topics include how IVIG can help those with LEMS, how the therapy is given, and more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-lambert-eaton-myasthenic-syndrome\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-21T16:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Christine Leduc, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Christine Leduc, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-lambert-eaton-myasthenic-syndrome\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-lambert-eaton-myasthenic-syndrome\\\/\"},\"author\":{\"name\":\"Dr. Christine Leduc, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/0d161a7a3c2b0cf54ab0cf25c936dd87\"},\"headline\":\"IVIG for Lambert-Eaton Myasthenic Syndrome\",\"datePublished\":\"2024-08-21T16:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-lambert-eaton-myasthenic-syndrome\\\/\"},\"wordCount\":721,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-lambert-eaton-myasthenic-syndrome\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/lems.jpg\",\"keywords\":[\"Dr. Christine Leduc\"],\"articleSection\":[\"IVIG\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-lambert-eaton-myasthenic-syndrome\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-lambert-eaton-myasthenic-syndrome\\\/\",\"name\":\"IVIG for Lambert-Eaton Myasthenic Syndrome - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-lambert-eaton-myasthenic-syndrome\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-lambert-eaton-myasthenic-syndrome\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/lems.jpg\",\"datePublished\":\"2024-08-21T16:00:00+00:00\",\"description\":\"Read about IVIG for Lambert-Eaton Myasthenic Syndrome. Topics include how IVIG can help those with LEMS, how the therapy is given, and more.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-lambert-eaton-myasthenic-syndrome\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-lambert-eaton-myasthenic-syndrome\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-lambert-eaton-myasthenic-syndrome\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/lems.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/lems.jpg\",\"width\":1280,\"height\":853,\"caption\":\"A man with muscle weakness in the arms from Lambert-Eaton myasthenic syndrome\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-lambert-eaton-myasthenic-syndrome\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IVIG for Lambert-Eaton Myasthenic Syndrome\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/0d161a7a3c2b0cf54ab0cf25c936dd87\",\"name\":\"Dr. Christine Leduc, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"caption\":\"Dr. Christine Leduc, PharmD\"},\"description\":\"Dr. Christine Leduc, PharmD, was born and raised in Irvine, CA. She attended college at Midwestern University, where she graduated cum laude. The most rewarding part of her job is suggesting lifestyle changes, educating patients on how their medication works, and precepting future pharmacists. Her areas of expertise are customer service and knowledge of specialty medication. Having worked in the service industry in the past, she has gained the customer service skills necessary to understand the needs of her patients. Dr. Leduc is currently precepting students from Marshall B. Ketchum University, University of Kansas, and Midwestern University. In her free time, she enjoys traveling, baking, and gardening. See Author Biography\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/christine-leduc\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IVIG for Lambert-Eaton Myasthenic Syndrome - AmeriPharma\u00ae Specialty Care","description":"Read about IVIG for Lambert-Eaton Myasthenic Syndrome. Topics include how IVIG can help those with LEMS, how the therapy is given, and more.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-lambert-eaton-myasthenic-syndrome\/","og_locale":"es_MX","og_type":"article","og_title":"IVIG for Lambert-Eaton Myasthenic Syndrome - AmeriPharma\u00ae Specialty Care","og_description":"Read about IVIG for Lambert-Eaton Myasthenic Syndrome. Topics include how IVIG can help those with LEMS, how the therapy is given, and more.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-lambert-eaton-myasthenic-syndrome\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2024-08-21T16:00:00+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems.jpg","type":"image\/jpeg"}],"author":"Dr. Christine Leduc, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Christine Leduc, PharmD","Est. reading time":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-lambert-eaton-myasthenic-syndrome\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-lambert-eaton-myasthenic-syndrome\/"},"author":{"name":"Dr. Christine Leduc, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/0d161a7a3c2b0cf54ab0cf25c936dd87"},"headline":"IVIG for Lambert-Eaton Myasthenic Syndrome","datePublished":"2024-08-21T16:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-lambert-eaton-myasthenic-syndrome\/"},"wordCount":721,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-lambert-eaton-myasthenic-syndrome\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems.jpg","keywords":["Dr. Christine Leduc"],"articleSection":["IVIG"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-lambert-eaton-myasthenic-syndrome\/","url":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-lambert-eaton-myasthenic-syndrome\/","name":"IVIG for Lambert-Eaton Myasthenic Syndrome - AmeriPharma\u00ae Specialty Care","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-lambert-eaton-myasthenic-syndrome\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-lambert-eaton-myasthenic-syndrome\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems.jpg","datePublished":"2024-08-21T16:00:00+00:00","description":"Read about IVIG for Lambert-Eaton Myasthenic Syndrome. Topics include how IVIG can help those with LEMS, how the therapy is given, and more.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-lambert-eaton-myasthenic-syndrome\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-lambert-eaton-myasthenic-syndrome\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-lambert-eaton-myasthenic-syndrome\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems.jpg","width":1280,"height":853,"caption":"A man with muscle weakness in the arms from Lambert-Eaton myasthenic syndrome"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-lambert-eaton-myasthenic-syndrome\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/vi\/"},{"@type":"ListItem","position":2,"name":"IVIG for Lambert-Eaton Myasthenic Syndrome"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/0d161a7a3c2b0cf54ab0cf25c936dd87","name":"Dra. Christine Leduc, PharmD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","caption":"Dr. Christine Leduc, PharmD"},"description":"La Dra. Christine Leduc, doctora en farmacia, naci\u00f3 y creci\u00f3 en Irvine, California. Curs\u00f3 estudios universitarios en la Universidad Midwestern, donde se gradu\u00f3 con honores. Lo m\u00e1s gratificante de su trabajo es sugerir cambios en el estilo de vida, educar a los pacientes sobre el funcionamiento de sus medicamentos y ser tutora de futuros farmac\u00e9uticos. Sus \u00e1reas de especializaci\u00f3n son la atenci\u00f3n al cliente y el conocimiento de medicamentos especializados. Tras haber trabajado en el sector servicios, ha adquirido las habilidades de atenci\u00f3n al cliente necesarias para comprender las necesidades de sus pacientes. Actualmente, la Dra. Leduc imparte clases a estudiantes de la Universidad Marshall B. Ketchum, la Universidad de Kansas y la Universidad Midwestern. En su tiempo libre, disfruta de viajar, la reposter\u00eda y la jardiner\u00eda. Ver biograf\u00eda de la autora.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Christine Leduc, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"},"uagb_comment_info":0,"uagb_excerpt":"Lambert-Eaton myasthenic syndrome (LEMS) is a rare autoimmune disorder that affects 2.8 million individuals worldwide. In the US, around 400 individuals are diagnosed with LEMS.\u00a0LEMS is a rare autoimmune neuromuscular junction disorder caused by an immune attack.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/lems.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Christine Leduc, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/ivig\/\" rel=\"category tag\">IVIG<\/a>","rttpg_excerpt":"Lambert-Eaton myasthenic syndrome (LEMS) is a rare autoimmune disorder that affects 2.8 million individuals worldwide. In the US, around 400 individuals are diagnosed with LEMS.\u00a0LEMS is a rare autoimmune neuromuscular junction disorder caused by an immune attack.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/26456","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=26456"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/26456\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/26459"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=26456"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=26456"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=26456"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}